Limax Biosciences, a spinout from the Wyss Institute at Harvard University, has developed a fully degradable hydrogel-based material has strong adhesion to difficult to attach surfaces. HemoMax has hundreds of times higher matrix mechanical toughness beyond native tissue and superior adhesive performance to commercial hemostatic patches and fibrin glues. Our internationally patented technology supported by our peer reviewed papers in top journals have shown that this approach can withstand high pressures and serve as a hemostatic agent in advanced bleeding scenarios. Hemomax is unlike any other medical adhesive on the market today. It’s tough, stimulating, and dual-layer structure is flexible and strong to adapt to tissue movements, is biocompatible, is antimicrobial, and is quick to apply. With a tunable degradation profile, it can be fully reabsorbed in weeks to months, or may be totally non-degradable.